Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study suggests evaluations of ACO programs may need to consider patient utilization of clinical, economic benefits

Payment incentives implemented with a commercial accountable care organization (ACO) initiative in Massachusetts -Blue Cross Blue Shield's Alternative Quality Contract (AQC) - were associated with lower spending for Medicare enrollees served by the provider groups participating in the AQC, findings that suggest that evaluations of ACO programs may need to consider the implications for other patient populations to assess their full clinical and economic benefits, according to a study in the August 28 issue of JAMA.

29 Aug 2013

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed - a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

29 Aug 2013

New clinical recommendations urge women to maintain periodontal health during pregnancy

When a woman becomes pregnant, she knows it is important to maintain a healthy lifestyle to ensure both the health of herself and the health of her baby. New clinical recommendations from the American Academy of Periodontology and the Eurpean Federation of Periodontology urge pregnant women to maintain periodontal health as well.

29 Aug 2013

Respicardia reports successful implant of remede System for CSA patients

Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced the successful implant of the first commercially-available remede system for patients with Central Sleep Apnea.

28 Aug 2013

New polymer additives enhance ability of oral drugs to reach bloodstream

All too often, when a person takes a pill full of a potent and effective drug, the drug passes straight through the body, not reaching the organ where it is needed — a waste of money and inconvenient if it is a cold medicine, but potentially dire if it is a treatment for a serious illness.

28 Aug 2013

Genetic variant linked with increased risk of CHD in type 2 diabetic patients

Joslin scientists, in collaboration with researchers from the Harvard School of Public Health and Italian research institutes, have identified a previously unknown genetic variant associated with an increased risk of coronary heart disease (CHD) in type 2 diabetic patients.

28 Aug 2013

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

Women undergoing treatment for breast cancer are widely prescribed calcium and vitamin D supplements to prevent and manage osteoporosis, an unwanted side effect of breast cancer therapies.

28 Aug 2013

Personalised management: The only way to close mortality gap for AF patients

Personalised management is the only way to close the mortality gap for patients with atrial fibrillation, according to an ESC consensus paper presented at ESC Congress 2013 by Professor Paulus Kirchhof (UK).

27 Aug 2013

Unique computer technology opens up discovery of smarter drugs to treat illnesses

A unique computer technology that opens up the discovery of smarter drugs to treat major illnesses including heart disease has been invented by University of Strathclyde scientists.

27 Aug 2013

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Galderma Laboratories, L.P. announced that the U.S. Food and Drug Administration has approved Mirvaso (brimonidine) topical gel, 0.33% for the topical treatment of the facial erythema (redness) of rosacea in adults 18 years of age or older. Applied once daily, Mirvaso works quickly to reduce the redness of rosacea and lasts up to 12 hours. Galderma expects Mirvaso to be available in pharmacies September 2013.

27 Aug 2013

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.

23 Aug 2013

Healthy and obese kids who participated in lifestyle modification program show improved heart health

A UCLA School of Nursing study has found that both healthy-weight and obese children who participated in an intensive lifestyle modification program significantly improved their metabolic and cardiovascular health despite little weight loss.

23 Aug 2013

Study confirms exposure to arsenic in drinking water can impair lung function

A new study confirms that exposure to low to moderate amounts of arsenic in drinking water can impair lung function. Doses of about 120 parts per billion of arsenic in well water-about 12 times the dose generally considered safe-produced lung damage comparable to decades of smoking tobacco. Smoking, especially by males, made arsenic-related damage even worse.

23 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

Childhood obesity: an interview with Dr. Kevin Hall, NIDDK, National Institutes of Health, Bethesda, USA

Our research uses mathematical modelling to quantify calorie intake as children grow at a healthy rate as well as when they develop obesity. We showed that the development of childhood obesity required a much greater increase in calories than previously thought since prior estimates did not properly account for metabolic changes as children grow.

21 Aug 2013

Hypertension researcher receives Distinguished Scientist title from AHA

Kenneth Bernstein, MD, a Cedars-Sinai pathologist and scientific researcher known for expanding the understanding of a collection of proteins important in controlling blood pressure as well as heart and renal diseases, has been named a 2013 Distinguished Scientist by the American Heart Association.

21 Aug 2013

Jersey Shore receives accreditation from BSCN for providing high quality care

Jersey Shore University Medical Center's bariatric surgery program has been accredited as a Level 2 facility under the Bariatric Surgery Center Network (BSCN) Accreditation Program of the American College of Surgeons (ACS). The accreditation demonstrates the hospital's commitment to providing the highest quality care for bariatric surgery patients.

21 Aug 2013

High levels of urinary albumin-to-creatinine ratio linked with greater risk of CHD in black individuals

In a large national study, higher levels of the urinary albumin-to-creatinine ratio was associated with greater risk of incident but not recurrent coronary heart disease in black individuals when compared with white individuals, according to a study in the August 21 issue of JAMA.

21 Aug 2013

Implementation of large-scale hypertension program linked with doubling of hypertension control rates

Implementation of a large-scale hypertension program that included evidence-based guidelines and development and sharing of performance metrics was associated with a near-doubling of hypertension control between 2001 and 2009, compared to only modest improvements in state and national control rates, according to a study in the August 21 issue of JAMA.

21 Aug 2013

Study: Pregnant women with gestational diabetes lose over an hour of sleep each night

Women diagnosed with gestational diabetes are nearly seven times more likely to have obstructive sleep apnea than other pregnant women, according to a recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).

21 Aug 2013

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Study suggests evaluations of ACO programs may need to consider patient utilization of clinical, economic benefits

Scientists create polymer additives that enhance orally administered drugs to reach bloodstream

New clinical recommendations urge women to maintain periodontal health during pregnancy

Respicardia reports successful implant of remede System for CSA patients

New polymer additives enhance ability of oral drugs to reach bloodstream

Genetic variant linked with increased risk of CHD in type 2 diabetic patients

Daily doses of calcium and vitamin supplements may not prevent loss of BMD in women

Personalised management: The only way to close mortality gap for AF patients

Unique computer technology opens up discovery of smarter drugs to treat illnesses

FDA approves Galderma's Mirvaso topical gel for facial erythema of rosacea

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Healthy and obese kids who participated in lifestyle modification program show improved heart health

Study confirms exposure to arsenic in drinking water can impair lung function

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Childhood obesity: an interview with Dr. Kevin Hall, NIDDK, National Institutes of Health, Bethesda, USA

Hypertension researcher receives Distinguished Scientist title from AHA

Jersey Shore receives accreditation from BSCN for providing high quality care

High levels of urinary albumin-to-creatinine ratio linked with greater risk of CHD in black individuals

Implementation of large-scale hypertension program linked with doubling of hypertension control rates

Study: Pregnant women with gestational diabetes lose over an hour of sleep each night

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Cardiovascular Disease News and Research

Latest Cardiovascular Disease News and Research

Innovating for impact: Jordi Labs on aligning methodologies with FDA expectation

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Newsletters you may be interested in